Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Sep 30, 2025 | (FY)Mar 31, 2025 | (Q6)Sep 30, 2024 | (FY)Mar 31, 2024 | (Q6)Sep 30, 2023 | (FY)Mar 31, 2023 | (Q6)Sep 30, 2022 | (FY)Mar 31, 2022 | (Q6)Sep 30, 2021 | (FY)Mar 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | 34.84%446.41M | ---- | 70.60%331.06M | ---- | -20.50%194.06M | ---- | -25.93%244.1M | ---- | -27.77%329.54M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | -26.70%-7.65M | ---- | 23.96%-6.04M | ---- | -81.64%-7.95M | ---- | -798.15%-4.37M | ---- | 64.99%-487K |
| Attributable subsidiary (profit) loss | ---- | -33.05%-18.15M | ---- | -1.48%-13.64M | ---- | -75.60%-13.44M | ---- | 22.52%-7.65M | ---- | 8.19%-9.88M |
| Impairment and provisions: | ---- | 592.84%20.66M | ---- | -110.93%-4.19M | ---- | 328.95%38.37M | ---- | -89.85%8.95M | ---- | 3,589.31%88.14M |
| -Impairment of property, plant and equipment (reversal) | ---- | ---- | ---- | -200.00%-14.84M | ---- | --14.84M | ---- | ---- | ---- | ---- |
| -Impairment of trade receivables (reversal) | ---- | 22.50%21.85M | ---- | 55.94%17.84M | ---- | 150.53%11.44M | ---- | 381.50%4.57M | ---- | 35.79%-1.62M |
| -Impairment of goodwill | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --89.76M |
| -Other impairments and provisions | ---- | 83.43%-1.19M | ---- | -159.48%-7.19M | ---- | 176.18%12.09M | ---- | --4.38M | ---- | ---- |
| Asset sale loss (gain): | ---- | -114.92%-923K | ---- | 209.93%6.19M | ---- | -876.41%-5.63M | ---- | 24.57%725K | ---- | 103.49%582K |
| -Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | --5.3M | ---- | ---- | ---- | ---- | ---- | ---- |
| -Loss (gain) on sale of property, machinery and equipment | ---- | -203.36%-923K | ---- | 229.61%893K | ---- | -195.03%-689K | ---- | 24.57%725K | ---- | 108.97%582K |
| -Loss (gain) from selling other assets | ---- | ---- | ---- | ---- | ---- | ---4.94M | ---- | ---- | ---- | ---- |
| Depreciation and amortization: | ---- | 16.06%125.16M | ---- | -31.44%107.84M | ---- | 14.23%157.29M | ---- | 47.15%137.7M | ---- | 48.66%93.58M |
| -Amortization of intangible assets | ---- | 34.00%17.04M | ---- | -10.25%12.72M | ---- | 148.26%14.17M | ---- | 11,546.94%5.71M | ---- | -26.87%49K |
| Financial expense | ---- | -80.21%5.19M | ---- | -16.35%26.24M | ---- | 6.37%31.37M | ---- | 131.25%29.49M | ---- | 101.84%12.75M |
| Exchange Loss (gain) | ---- | 44.62%-1.81M | ---- | -170.91%-3.26M | ---- | 185.65%4.6M | ---- | 163.97%1.61M | ---- | -531.73%-2.52M |
| Special items | ---- | 73.14%-14.65M | ---- | ---54.55M | ---- | ---- | ---- | --3.57M | ---- | ---- |
| Operating profit before the change of operating capital | ---- | 42.25%554.25M | ---- | -2.26%389.64M | ---- | -3.73%398.67M | ---- | -19.07%414.11M | ---- | 3.44%511.71M |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | 461.20%32.17M | ---- | 82.74%-8.91M | ---- | -136.97%-51.62M | ---- | -184.24%-21.78M | ---- | 439.82%25.86M |
| Accounts receivable (increase)decrease | ---- | -197.28%-7.22M | ---- | -93.27%7.42M | ---- | 277.85%110.19M | ---- | -819.43%-61.96M | ---- | -82.05%8.61M |
| Accounts payable increase (decrease) | ---- | 103.78%4.99M | ---- | -108.30%-131.87M | ---- | -159.45%-63.31M | ---- | 465.30%106.49M | ---- | 142.48%18.84M |
| Special items for working capital changes | ---- | ---- | ---- | ---- | ---- | 121.07%72.75M | ---- | -77.55%32.91M | ---- | 220.36%146.57M |
| Cash from business operations | ---- | 127.95%584.19M | ---- | -45.08%256.28M | ---- | -0.66%466.69M | ---- | -33.98%469.77M | ---- | 92.87%711.59M |
| Other taxs | ---- | -97.05%-70.18M | ---- | -1.73%-35.62M | ---- | 13.91%-35.01M | ---- | 32.75%-40.67M | ---- | 5.99%-60.47M |
| Special items of business | -4.88%215.39M | ---- | 1,255.18%226.44M | ---- | -79.15%16.71M | ---- | -41.56%80.16M | ---- | -23.05%137.17M | ---- |
| Net cash from operations | -4.88%215.39M | 132.93%514.01M | 1,255.18%226.44M | -48.88%220.67M | -79.15%16.71M | 0.60%431.68M | -41.56%80.16M | -34.10%429.1M | -23.05%137.17M | 113.75%651.12M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | 63.14%1.22M | 14.62%6.09M | -78.02%746K | -33.09%5.32M | 117.56%3.39M | 81.64%7.95M | 700.00%1.56M | 798.15%4.37M | 50.00%195K | -64.99%487K |
| Dividend received - investment | -83.19%701K | -83.85%4.17M | --4.17M | 181.56%25.82M | ---- | 22.06%9.17M | ---- | 7.31%7.51M | ---- | -33.33%7M |
| Restricted cash (increase) decrease | -90.88%240K | -126.88%-3.61M | 104.70%2.63M | 560.35%13.43M | ---56M | 111.24%2.03M | ---- | ---18.09M | ---- | ---- |
| Sale of fixed assets | --2.2M | 16.93%1.82M | ---- | -93.08%1.55M | 649.01%1.13M | 429.19%22.43M | -30.41%151K | 116.78%4.24M | -68.96%217K | -94.78%1.96M |
| Purchase of fixed assets | -183.44%-339M | -95.75%-364.86M | -64.57%-119.61M | 14.05%-186.39M | -391.39%-72.68M | -57.23%-216.87M | 51.78%-14.79M | 5.30%-137.93M | 9.86%-30.68M | -107.40%-145.65M |
| Selling intangible assets | ---- | ---- | ---- | ---- | ---- | --23.56M | ---- | ---- | ---- | ---- |
| Purchase of intangible assets | -225.61%-5.48M | 72.97%-28.12M | 97.63%-1.68M | -171.51%-104.02M | ---70.99M | -193.87%-38.31M | ---- | 38.09%-13.04M | ---13M | 64.83%-21.06M |
| Sale of subsidiaries | ---- | ---- | ---- | --1.81M | ---- | ---- | ---- | ---- | ---- | ---- |
| Acquisition of subsidiaries | ---- | ---- | ---- | ---- | ---- | 103.79%2.67M | ---- | -1,496.73%-70.54M | ---- | --5.05M |
| Cash on investment | ---- | ---- | ---- | ---- | ---- | 83.57%-2M | 83.33%-2M | ---12.17M | 37.82%-12M | ---- |
| Other items in the investment business | -120.82%-591K | -32.43%-2.05M | --2.84M | -167.39%-1.55M | ---- | -45.50%2.3M | -48.17%4.54M | 0.19%4.22M | -32.47%8.75M | 101.68%4.21M |
| Net cash from investment operations | -207.22%-340.71M | -58.40%-386.56M | 43.17%-110.9M | -30.44%-244.04M | -1,750.92%-195.14M | 19.16%-187.09M | 77.33%-10.54M | -56.36%-231.42M | 53.28%-46.51M | 57.88%-148.01M |
| Net cash before financing | -208.47%-125.32M | 645.33%127.45M | 164.75%115.53M | -109.56%-23.37M | -356.32%-178.43M | 23.73%244.59M | -23.21%69.61M | -60.71%197.68M | 15.18%90.65M | 1,175.43%503.12M |
| Cash flow from financing activities | ||||||||||
| New borrowing | 365.92%257.7M | 21.08%335.26M | -77.40%55.31M | 95.31%276.9M | 43.98%244.77M | -57.08%141.78M | -32.00%170M | 58.55%330.36M | 66.67%250M | -40.47%208.37M |
| Refund | -270.84%-172.44M | 43.55%-224.1M | 86.36%-46.5M | -30.59%-397M | -67.16%-341M | -41.40%-304M | -27.50%-204M | 27.78%-215M | 31.91%-160M | -357.98%-297.69M |
| Interest paid - financing | -22.06%-4.78M | -7.72%-13M | -6.01%-3.92M | 25.27%-12.07M | 54.65%-3.69M | 24.04%-16.16M | -70.83%-8.15M | -86.21%-21.27M | -49.75%-4.77M | -82.47%-11.42M |
| Dividends paid - financing | ---- | 59.05%-63.51M | -71.45%-18.34M | 4.41%-155.09M | 78.64%-10.7M | -106.30%-162.24M | -35.16%-50.08M | 76.67%-78.65M | ---37.05M | -88.82%-337.13M |
| Absorb investment income | ---- | 3,200.00%165M | --4K | -93.38%5M | ---- | -51.35%75.5M | ---- | 94.00%155.2M | ---- | --80M |
| Issuance expenses and redemption of securities expenses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -12.71%-24.61M | ---- | ---21.84M |
| Other items of the financing business | 1,897.82%24.79M | 253.33%82.8M | 24.81%-1.38M | ---54M | 86.10%-1.83M | ---- | -121.67%-13.19M | 468.75%84.46M | 715.52%60.89M | -181.78%-22.9M |
| Net cash from financing operations | 738.49%98.26M | 182.00%277.71M | 86.35%-15.39M | -18.97%-338.66M | -6.97%-112.77M | -245.88%-284.66M | -196.66%-105.42M | 144.65%195.13M | 211.20%109.07M | -468.93%-437.06M |
| Effect of rate | 283.78%408K | 542.03%3.61M | -45.10%-222K | -124.76%-816K | -103.16%-153K | 331.72%3.3M | 2,136.97%4.85M | -282.78%-1.42M | -193.70%-238K | 248.88%778K |
| Net Cash | -127.02%-27.06M | 211.91%405.16M | 134.39%100.14M | -803.59%-362.03M | -713.25%-291.2M | -110.20%-40.07M | -117.93%-35.81M | 494.66%392.81M | 1,131.02%199.72M | -7.85%66.06M |
| Begining period cash | 182.67%632.55M | -61.85%223.78M | -61.85%223.78M | -5.90%586.63M | -5.90%586.63M | 168.69%623.4M | 168.69%623.4M | 40.46%232.01M | 40.46%232.01M | 77.09%165.18M |
| Cash at the end | 87.18%605.89M | 182.67%632.55M | 9.63%323.7M | -61.85%223.78M | -50.16%295.27M | -5.90%586.63M | 37.30%592.44M | 168.69%623.4M | 195.42%431.49M | 40.46%232.01M |
| Cash balance analysis | ||||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Hong Kong Lixin Dehao Certified Public Accountants Limited | -- | Hong Kong Lixin Dehao Certified Public Accountants Limited | -- | Hong Kong Lixin Dehao Certified Public Accountants Limited | -- | Hong Kong Lixin Dehao Certified Public Accountants Limited | -- | Hong Kong Lixin Dehao Certified Public Accountants Limited |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.